Nusse Roeland

DirectorBIO-TECHNE Corp (TECH) · full profile →Form 4 · filed Sep 1, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$718K
Net Open-Market Flow
-$718K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 30, 2023Option exercise(M)16K$22.95$367K61K
Aug 30, 2023Option exercise(M)16K$21.85$350K45K
Aug 30, 2023Sell(S)9K$80.32$718K52K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 30, 2023Option exercise(M)16K$00
Aug 30, 2023Option exercise(M)16K$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-23-017413) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.